PCVD12: Effects of an Educational Campaign on Medication Use for Coronary Artery Disease (Cad) (original) (raw)
The Know & Go! program improves knowledge for patients with coronary heart disease in pilot testing
Sally Rankin
Heart & Lung: The Journal of Acute and Critical Care, 2010
View PDFchevron_right
Adherence to Prescribing Guideline-Directed Medical Therapy at Hospital Discharge in Subjects With Acute Coronary Syndrome, and the Relationship With Mortality
Hanan Abouzaid
Cureus
View PDFchevron_right
The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients
Surarong Chinwong
Pharmacy World & Science, 2004
View PDFchevron_right
Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial
Patricia Davidson
Trials, 2012
View PDFchevron_right
Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors
Joe Hung
Cardiovascular Therapeutics, 2016
View PDFchevron_right
Effectiveness of lipid-lowering medications in outpatients with coronary heart disease in the Department of Veterans Affairs System * * The views expressed in this work do not necessarily represent the views of the Department of Veterans Affairs
siamak noorbaloochi
American Journal of Cardiology, 2003
View PDFchevron_right
Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications
Christian Matter
PLoS ONE, 2014
View PDFchevron_right
Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction
Scott Harding
Heart, Lung and Circulation, 2019
View PDFchevron_right
Five-year follow-up of drug utilization for secondary prevention in coronary artery disease
Mesut Sancar
Pharmacy World & Science, 2008
View PDFchevron_right
Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial
Renaldo Battista, R. Blais
QJM, 2004
View PDFchevron_right
Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study
Alvaro Avezum
The American Journal of Medicine, 2004
View PDFchevron_right
Patient Awareness of Sustained Commitment to Clopidogrel Use After Percutaneous Coronary Intervention for Treatment of Coronary Heart Disease in the Contemporary Era
Anjan Gupta
Journal of the American College of Cardiology, 2012
View PDFchevron_right
Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective
Trond Røed Pettersen
International Journal of Nursing Studies, 2018
View PDFchevron_right
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study
Rula Shami
International Journal of Clinical Pharmacy
View PDFchevron_right
MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease
Beate Garcia
Pharmacoepidemiology and Drug Safety, 2010
View PDFchevron_right
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes
Baris Gencer, Christian Matter
European journal of internal medicine, 2015
View PDFchevron_right
Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost
Ilene Zuckerman
The American journal of managed care, 2004
View PDFchevron_right
Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial
Tiffany Radcliff
JAMA internal medicine, 2014
View PDFchevron_right
Seventeen-month follow-up of drug utilization for secondary prevention in coronary artery disease
Omar Ismail
2012
View PDFchevron_right
A Call for Pharmacists to Improve the Care of Patients with Myocardial Infarction
Kathleen Stringer
Pharmacotherapy, 2001
View PDFchevron_right
An Intervention to Improve Secondary Prevention of Coronary Heart Disease
Robyn Burns Schaiff
Archives of Internal Medicine, 2007
View PDFchevron_right
Underuse of cardioprotective medications in patients prior to acute myocardial infarction
Branko Kopjar
The American Journal of Cardiology, 2003
View PDFchevron_right
ADHERENCE TO EVIDENCE-BASED THERAPIES AND MODIFIABLE RISK FACTORS IN PATIENTS WITH CORONARY ARTERY DISEASE - THE HLCP PROJECT
JAVAD RAMEZANI
2006
View PDFchevron_right
Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction : Data From the National Registry of Myocardial Infarction 3
Judith Malmgren
Circulation, 2001
View PDFchevron_right